Table 1.
General characteristics of the study population.
| Study Population | Males | Females | p Value | |
|---|---|---|---|---|
| Total (N) | 34,669 | 22,554 (65.1%) | 12,115 (34.9%) | <0.001 † |
| LDL-C ≥ 4.9 mmol/L (N, %) |
3434 (9.9%) | 1805 (8.0%) | 1629 (13.4%) | <0.001 * |
| LDL-C ≥ 6.5 mmol/L (N, %) |
371 (1.1%) | 157 (0.7%) | 214 (1.8%) | <0.001 * |
| LDL-C ≥ 8.5 mmol/L (N, %) |
36 (0.1%) | 13 (0.1%) | 23 (0.2%) | <0.001 * |
| DM (N, %) | 4081 (11.8%) | 2244 (9.9%) | 1837 (15.2%) | <0.001 * |
| AH (N, %) | 16,627 (48.0%) | 10,458 (46.4%) | 6169 (50.9%) | <0.001 * |
| DM and AH (N, %) | 3229 (9.3%) | 1743 (7.7%) | 1486 (12.3%) | <0.001 * |
| Median age (years) |
67 | 64 | 73 | <0.001 * |
| Median LDL-C (mmol/L/) | 3.4 | 3.3 | 3.5 | <0.001 * |
LDL—low density lipoprotein cholesterol; DM—diabetes mellitus; AH—arterial hypertension. † Statistically significant difference in proportion between sexes in a patient group. * Statistically significant difference between sexes.